Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × vistusertib × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 5 Breast 5 Lymphoid 3 Genitourinary 3 Tumor-Agnostic 2 Other solid neoplasm 2 Gastrointestinal 2 CNS 2 Gynecologic 1

Conditions

Endometrial Neoplasms 1 Carcinoma 1

Interventions

Paclitaxel 496 Carboplatin 456 Cisplatin 298 Bevacizumab 215 pembrolizumab 201 Gemcitabine 127 Cyclophosphamide 113 Topotecan 107 olaparib 105 liposomal doxorubicin 104 Radiotherapy 96 Taxes 93 Docetaxel 82 Brachytherapy 80 Doxorubicin 75 Drug Therapy 71 niraparib 66 Nivolumab 64 Magnetic Resonance Spectroscopy 58 Specimen Handling 55 fludarabine 52 Biopsy 52 Hyperthermic Intraperitoneal Chemotherapy 45 Filgrastim 43 durvalumab 42 Letrozole 41 Platinum 39 Oxaliplatin 39 Radiation 38 atezolizumab 37

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02730923 2024-02-13

VICTORIA

Centre Leon Berard

Phase 1/2 Unknown

Carcinoma, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡